文献速递肝病

低每日步数与社区肝硬化患者高住院和死亡风险相关

Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-03-21

本研究纳入116例社区肝硬化患者,使用个人活动追踪器监测每日步数并结合衰弱评估,发现最低四分位步数(<1200步/天)与住院和死亡风险独立相关,且步数预测效能与现有衰弱指标相似;联合运动专用手机应用可提高追踪器使用率。

要点

  • 每日步数<1200步的肝硬化患者住院和死亡风险显著升高。
  • 步数对住院和死亡的预测能力与6分钟步行试验和步速测试相似。
  • 联合运动专用手机应用可提高活动追踪器的使用和步数报告率。

核心结论

  • 每日步数可预测肝硬化患者的住院率和死亡率,预测效能与当前标准衰弱指标相似。
  • 联合运动专用智能手机应用与个人活动追踪器使用率和步数报告率升高相关。

研究设计与样本

  • 研究纳入116例社区肝硬化患者,年龄56±11岁,男性55%,体重指数31±7,MELD-Na评分15±7。
  • 所有参与者接受肝脏衰弱指数、6分钟步行试验和步速测试评估,并佩戴个人活动追踪器监测步数,部分参与者同时使用运动与肝脏健康手机应用(EL-FIT)。
  • 分析第一周每日步数和衰弱指标作为住院和死亡的预测因素。

主要发现

  • 随访期间住院率为55%,死亡率为15%。
  • Kaplan-Meier曲线显示最低四分位步数(<1200步/天)患者再住院和死亡增加。
  • 调整MELD-Na和EL-FIT使用后,最低四分位步数与住院风险相关(HR 1.90,95%CI 1.09-3.30),与死亡风险相关(HR 3.46,95%CI 1.23-9.68)。
  • 6分钟步行试验每增加100米与住院风险降低相关(HR 0.63,95%CI 0.47-0.83),与死亡风险降低相关(HR 0.66,95%CI 0.44-0.99)。
  • 步速测试与住院风险降低相关(HR 0.29,95%CI 0.11-0.72),与死亡风险降低相关(HR 0.21,95%CI 0.05-0.84)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Daily step count measures cardiorespiratory fitness and has been associated with clinical outcomes. However, its utility in patients with cirrhosis remains largely unexplored. We aimed to investigate the association between step count, frailty metrics, and clinical outcomes in cirrhosis. METHODS: All participants underwent frailty evaluation with the liver frailty index, 6-minute walk test, and gait speed test. To monitor step count, participants were given a personal activity tracker (PAT). A subset also was invited to use Exercise and Liver FITness (EL-FIT). Daily step counts from the first week of PAT use and frailty metrics were investigated as predictors of hospital admission and mortality. RESULTS: There were 116 patients included (age, 56 ± 11 y; male, 55%; body mass index, 31 ± 7; model for end-stage liver disease-sodium, 15 ± 7). The main etiologies of cirrhosis were alcohol-related (33%) and nonalcoholic steatohepatitis (30%). Monitoring for the week was accomplished in 80% of participants given both PAT+EL-FIT vs 62% in those with PAT only (P = .04). During follow-up evaluation, hospital admission was observed in 55% and death in 15%. Kaplan-Meir curves showed increased readmission and deaths among patients performing in the lowest quartile (ie, <1200 steps/d). When adjusted by model for end-stage liver disease-sodium and EL-FIT use, the lowest quartile was associated with hospital admission and death (hazard ratio, HR [95% confidence interval], 1.90 [1.09-3.30] and 3.46 [1.23-9.68], respectively), along with the 6-minute walk test (HR, 0.63 [0.47-0.83] and 0.66 [0.44-0.99] per 100 m, respectively) and gait speed test (HR, 0.29 [0.11-0.72] and 0.21 [0.05-0.84], respectively). CONCLUSIONS: Daily step count predicted hospital admission and mortality rates in patients with cirrhosis, similar to the current standard frailty metrics. Incorporation of a physical training-dedicated smartphone application was associated with increased PAT use and step reporting.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lin FP, Bloomer PM, Grubbs RK, et al. Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022. PMID: 35331941. doi:10.1016/j.cgh.2022.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。